PSI-Immune
Phase 2 Recruiting
880 enrolled
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Phase 3 Recruiting
700 enrolled
NIMA
Phase NA Recruiting
120 enrolled
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Phase 1 Recruiting
145 enrolled
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Phase 1 Recruiting
51 enrolled
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
Phase 1 Recruiting
22 enrolled
KANDLELIT-012
Phase 3 Recruiting
477 enrolled
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
Phase NA Recruiting
70 enrolled
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Phase 3 Recruiting
800 enrolled
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Phase NA Recruiting
420 enrolled
TRIDENT-1
Phase 1/2 Recruiting
500 enrolled 5 FDA
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Phase NA Recruiting
400 enrolled
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Phase 1 Recruiting
188 enrolled
FORTE
Phase NA Recruiting
9,500 enrolled
CIRCULATE-US
Phase 2/3 Recruiting
1,912 enrolled
AZUR-4
Phase 2 Recruiting
120 enrolled
A Study of PHN-012 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
165 enrolled
SURGE
Phase NA Recruiting
300 enrolled
MIMICC
Phase NA Recruiting
2,500 enrolled
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Phase 1/2 Recruiting
47 enrolled
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 Recruiting
48 enrolled
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Phase 2/3 Recruiting
308 enrolled
REACH
Phase NA Recruiting
257 enrolled
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Phase 1 Recruiting
134 enrolled
SCOTI
Phase 2 Recruiting
50 enrolled
Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
Phase NA Recruiting
60 enrolled
FRUITFUL
Phase 2 Recruiting
60 enrolled
TRIUNITE-08
Phase 2 Recruiting
106 enrolled
Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
Phase 1/2 Recruiting
48 enrolled
PILDI
Phase 2 Recruiting
100 enrolled
NICHE
Phase 2 Recruiting
353 enrolled
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Phase 1 Recruiting
307 enrolled
Phase II Trial of Lung Chemoemobolization
Phase 2 Recruiting
30 enrolled
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Phase 1 Recruiting
80 enrolled
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Phase 1 Recruiting
330 enrolled
miR-CIPN#1
Phase NA Recruiting
90 enrolled
Quality Of Life In Colorectal Cancer Survivors
Phase NA Recruiting
368 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
EVEREST-2
Phase 1/2 Recruiting
474 enrolled
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Phase 1/2 Recruiting
159 enrolled
UOT WPXRT
Phase NA Recruiting
26 enrolled
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Phase 1 Recruiting
100 enrolled
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1 Recruiting
170 enrolled
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Phase 1/2 Recruiting
150 enrolled
CHIMERA
Phase 2 Recruiting
42 enrolled
Superhero
Phase 2 Recruiting
10 enrolled
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Phase NA Recruiting
414 enrolled
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Phase NA Recruiting
9 enrolled
COnCERTO
Phase 3 Recruiting
232 enrolled
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Phase 1/2 Recruiting
534 enrolled